Lupin receives US FDA approval for perindopril erbumine tablets

29 Jan 2010

1

Mumbai-based pharmaceuticals company Lupin Ltd has announced that the US Food and Drug Administration (US FDA) has granted final approval to its US subsidiary, Lupin Pharmaceuticals, Inc. (LPI) for its perindopril erbumine tablets, in 2mg, 4mg and 8mg dosages.

"Commercial shipments of the product will commence shortly," Lupin saidin a statement.

Lupin's perindopril erbumine tablets are AB-rated to Aceon tablets indicated for the treatment of patients with essential hypertension and can be used with conventional treatment for management of coronary artery disease.

Aceon had annual sales of approximately $24 million for the twelve months ended September 2009, based on IMS Health sales data.

Lupin products are marketed in over 70 countries in the world.

The company said it is among the Top 10 the fastest growing generics manufacturers in the two largest pharmaceutical markets of the world – The US, and Japan

In the US it is now  ranked 9th by prescriptions sales, growing at 92 per cent. In Japan it is ranked 7th, with a 23 per cent growth rate.

In India Lupin is  among the the fastest growing, Top 5 pharmaceutical firms as per ORG IMS - March 2009, and the fastest growing generics firm in South Africa, where it is ranked 6th with a YoY growth of 30 per cent (IMS)

Business History Videos

History of hovercraft Part 3...

Today I shall talk a bit more about the military plans for ...

By Kiron Kasbekar | Presenter: Kiron Kasbekar

History of hovercraft Part 2...

In this episode of our history of hovercraft, we shall exam...

By Kiron Kasbekar | Presenter: Kiron Kasbekar

History of Hovercraft Part 1...

If you’ve been a James Bond movie fan, you may recall seein...

By Kiron Kasbekar | Presenter: Kiron Kasbekar

History of Trams in India | ...

The video I am presenting to you is based on a script writt...

By Aniket Gupta | Presenter: Sheetal Gaikwad

view more